American Century Companies Inc. Acquires 793,640 Shares of DocGo Inc. $DCGO

American Century Companies Inc. lifted its holdings in DocGo Inc. (NASDAQ:DCGO) by 175.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,245,894 shares of the company’s stock after buying an additional 793,640 shares during the quarter. American Century Companies Inc. owned approximately 1.22% of DocGo worth $3,289,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of DCGO. Barclays PLC boosted its stake in DocGo by 14.5% during the fourth quarter. Barclays PLC now owns 154,456 shares of the company’s stock worth $655,000 after acquiring an additional 19,533 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of DocGo by 31.0% during the fourth quarter. Wells Fargo & Company MN now owns 57,463 shares of the company’s stock valued at $244,000 after purchasing an additional 13,584 shares during the last quarter. Ritholtz Wealth Management bought a new stake in shares of DocGo in the 1st quarter worth approximately $316,000. Price T Rowe Associates Inc. MD grew its stake in shares of DocGo by 33.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 75,872 shares of the company’s stock worth $322,000 after buying an additional 18,844 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of DocGo by 24.9% in the 4th quarter. Northern Trust Corp now owns 1,606,139 shares of the company’s stock worth $6,810,000 after buying an additional 320,133 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.

DocGo Trading Down 4.3%

DCGO stock opened at $1.56 on Friday. The stock’s 50 day simple moving average is $1.54 and its 200 day simple moving average is $2.15. DocGo Inc. has a 12-month low of $1.23 and a 12-month high of $5.68. The stock has a market capitalization of $152.58 million, a PE ratio of -8.21 and a beta of 0.96.

DocGo (NASDAQ:DCGO) last posted its earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.05). The business had revenue of $80.42 million during the quarter, compared to the consensus estimate of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. DocGo has set its FY 2025 guidance at EPS. On average, research analysts predict that DocGo Inc. will post 0.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on DCGO shares. Canaccord Genuity Group lifted their price objective on DocGo from $1.45 to $1.60 and gave the company a “hold” rating in a research note on Thursday, August 21st. BTIG Research downgraded DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Needham & Company LLC lowered their price target on DocGo from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $3.59.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.